Literature DB >> 19413680

Modelling the elastin, collagen and smooth muscle contribution to the duodenal mechanical behaviour in patients with systemic sclerosis.

F Gao1, D Liao, A M Drewes, H Gregersen.   

Abstract

Systemic sclerosis (SS) is a connective tissue disease that involves the gastrointestinal tract. Previous experiments have shown abnormal intestinal motility, dilatation, wall stiffening and impaired smooth muscle function. Consequently, understanding the association between intestinal wall mechanics, structure and function is important. The aim was to establish a model for differentiating the biomechanical remodelling of elastin, collagen and smooth muscle in the duodenum in SS patients. A duodenal distension protocol was used in six patients and five healthy controls. A theoretical model for evaluating the mechanical contributions of elastin, collagen and smooth muscle tone was established. The tension-strain curves computed from pressure and cross-sectional area data were analysed. The elastic modulus of elastin, the relationship between the collagen recruitment, collagen density and the active tension were calculated. The model fitted the clinical data well. The material constant for elastin in the patients was 30% lower than in the control group (P = 0.005). More collagen was recruited in patients than in healthy volunteers. Eighty percent of the collagen fibres were recruited at stretch ratio 0.85-2.26 (1.61 averaged) in patients and at the stretch ratio 2.55-3.73 (2.97 averaged) in healthy controls. The maximum active muscle tension and the corresponding strain were lowest in the patients (P = 0.01). The model can be used to determine the contribution of tissue components to the mechanical behaviour of duodenum. The stiffer wall in patient was due to the small stretch ratio for the maximum collagen recruitment but the muscle activity was also impaired.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413680     DOI: 10.1111/j.1365-2982.2009.01314.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

1.  Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

Authors:  Rebecca L DiMarco; Daniel R Hunt; Ruby E Dewi; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

2.  Mechanical characteristics of distension-evoked peristaltic contractions in the esophagus of systemic sclerosis patients.

Authors:  Hans Gregersen; Gerda E Villadsen; Donghua Liao
Journal:  Dig Dis Sci       Date:  2011-06-17       Impact factor: 3.199

3.  Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.

Authors:  George P Karamanolis; Stylianos Panopoulos; Anastasios Karlaftis; Konstantinos Denaxas; Dimitrios Kamberoglou; Petros P Sfikakis; Spiros D Ladas
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

4.  Biomechanical constitutive modeling of the gastrointestinal tissues: a systematic review.

Authors:  Bhavesh Patel; Alessio Gizzi; Javad Hashemi; Yousif Awakeem; Hans Gregersen; Ghassan Kassab
Journal:  Mater Des       Date:  2022-03-24       Impact factor: 9.417

5.  Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function.

Authors:  Steven Lammers; Devon Scott; Kendall Hunter; Wei Tan; Robin Shandas; Kurt R Stenmark
Journal:  Compr Physiol       Date:  2012-01-01       Impact factor: 9.090

6.  Remodeling of the rat distal colon in diabetes: function and ultrastructure.

Authors:  Marion J Siegman; Masumi Eto; Thomas M Butler
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-11       Impact factor: 4.249

7.  The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.

Authors:  George P Karamanolis; Stylianos Panopoulos; Konstantinos Denaxas; Anastasios Karlaftis; Alexandra Zorbala; Dimitrios Kamberoglou; Spiros D Ladas; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2016-09-01       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.